Brookdale Senior Living (BKD) Bank of America Global Healthcare Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Bank of America Global Healthcare Conference 2026 summary
13 May, 2026Strategic transformation and organizational changes
Entering a new era with recent leadership changes, including a new CEO and COO, and significant restructuring, reducing districts from 55 to 43 within months to optimize operations.
Disposing of underperforming assets, with 19 more communities to be sold in the coming months, aiming for a fully stabilized portfolio.
Organizational changes are now largely complete and expected to drive operational effectiveness as the company enters peak selling seasons.
Occupancy and growth drivers
Targeting occupancy above 83% for 2026, up from 81% in 2025, with long-term benchmarks set by pre-COVID and pre-acquisition highs near 89%.
Growth driven by demographic tailwinds (80+ population growing at 4%-5% CAGR), record-low new supply, and focused execution on low-occupancy communities.
Network selling strategies and SWAT teams are deployed to boost occupancy, especially in underperforming locations.
Expecting 1-3 percentage points of occupancy growth per year, with meaningful NOI and margin expansion as more communities surpass 90% occupancy.
Pricing strategy and revenue management
Implemented high single-digit in-place rate increases in January, with low double-digit increases in highly occupied communities, leveraging pricing power.
Pricing is managed centrally for effectiveness, using analytics and local market input, with product-type and occupancy-specific strategies.
Higher occupancy enables premium pricing and significant EBITDA per unit growth, with top-performing communities generating up to $21,000 per unit versus $4,800 in low-occupancy sites.
Latest events from Brookdale Senior Living
- Q1 2026 saw strong RevPAR and occupancy gains, improved profitability, and reaffirmed guidance.BKD
Q1 202613 May 2026 - Director elections, executive pay, and auditor ratification headline the 2026 annual meeting.BKD
Proxy filing30 Apr 2026 - Director elections, executive pay, and auditor ratification headline the annual meeting agenda.BKD
Proxy filing30 Apr 2026 - Record 2025 EBITDA and occupancy growth set the stage for robust 2026 performance.BKD
Q4 202510 Apr 2026 - Operational focus, targeted CapEx, and market-driven M&A support growth amid strong demand.BKD
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Q2 saw 20% Adjusted EBITDA growth, higher occupancy, but a wider net loss on higher costs.BKD
Q2 20241 Feb 2026 - 2026 targets $502–$516M Adjusted EBITDA and 8–9% RevPAR growth, led by operational transformation.BKD
Investor Day 202630 Jan 2026 - Q3 2024 delivered 15% EBITDA growth, higher occupancy, and $610M in acquisitions pending.BKD
Q3 202415 Jan 2026 - Strategic acquisitions, strong occupancy, and HealthPlus expansion drive positive 2025 outlook.BKD
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026